These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7236993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
    Cusack NJ, Hourani SM.
    Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
    [Abstract] [Full Text] [Related]

  • 4. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA, Hourani SM.
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS, Hourani SM.
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes.
    Gachet C, Cazenave JP, Ohlmann P, Hilf G, Wieland T, Jakobs KH.
    Eur J Biochem; 1992 Jul 01; 207(1):259-63. PubMed ID: 1321045
    [Abstract] [Full Text] [Related]

  • 10. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA, Hourani SM.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1013-8. PubMed ID: 8147900
    [Abstract] [Full Text] [Related]

  • 11. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ, Hourani SM.
    Br J Pharmacol; 1982 May 15; 76(1):221-7. PubMed ID: 6282375
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM, Hall DA, Nieman CJ.
    Br J Pharmacol; 1992 Feb 15; 105(2):453-7. PubMed ID: 1559134
    [Abstract] [Full Text] [Related]

  • 15. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V, Armstrong PC, Warner TD, Curzen N.
    Platelets; 2015 Feb 15; 26(7):689-92. PubMed ID: 25734957
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.
    Agarwal AK, Tandon NN, Greco NJ, Cusack NJ, Jamieson GA.
    Thromb Haemost; 1989 Dec 29; 62(4):1103-6. PubMed ID: 2617458
    [Abstract] [Full Text] [Related]

  • 17. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC, Figures WR, Scearce LM, Stewart GJ, Colman RF, Colman RW.
    J Biol Chem; 1985 Jul 05; 260(13):8078-83. PubMed ID: 2989276
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1991 May 01; 286(2):419-27. PubMed ID: 1910292
    [Abstract] [Full Text] [Related]

  • 19. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM.
    Thromb Haemost; 1997 May 01; 77(5):986-90. PubMed ID: 9184415
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.